Income
ICICI Prudential Fixed Maturity Plan - Series 77 - 1100 Days Plan L
Direct plan · Dividend · ICICI Prudential Mutual Fund
Risk: Low Risk
₹12.5471
NAV as of 17 Jul 2018
+0.01% day change
Other Plans of This Fund
ISININF109KB1IW8
Scheme Code134926
StructureClose Ended Schemes
AUM (avg. July - September 2018)₹0 Cr
Expense Ratio (as of 17 Jul 2018)0.02%
Min. Investment₹5,000
Inception Date6 Jul 2015
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
NAV history isn’t available yet for this scheme.
AUM Trend (₹ Cr, quarterly average)
Portfolio
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others0.00%
Top 5 Stocks0.00%
Top 10 Stocks0.00%
Top 3 Sectors0.00%
Other funds in Income
| Scheme | Plan | NAV |
|---|---|---|
| Aditya Birla Sun Life Fixed Maturity Plan - Series UQ (92 days) | Direct plan · Growth | ₹10.1879 |
| Aditya Birla Sun Life Fixed Maturity Plan - Series UR (85 days) | Direct plan · Growth | ₹10.1718 |
| Aditya Birla Sun Life Fixed Maturity Plan - Series US (100 days) | Direct plan · Growth | ₹10.2094 |
| Aditya Birla Sun Life Fixed Term Plan - Series TI (1837 days) | Direct plan · Growth | ₹13.5721 |
| Aditya Birla Sun Life Fixed Term Plan - Series TJ (1838 days) | Direct plan · Growth | ₹13.6352 |
| Aditya Birla Sun Life Fixed Term Plan - Series TQ (1879 days) | Direct plan · Growth | ₹13.3873 |
About This Scheme
Investment Objective
The investment objective of the Scheme is to seek to generate income by investing in a portfolio of fixed income securities/debt instruments maturing on or before the maturity of the Scheme
Official Documents
Scheme Information Document (PDF)
Scheme Summary (PDF)
Scheme Summary (XLS)
ICICI Prudential Asset Management Company Limited website
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch